Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ... Jama 321 (2), 175-187, 2019 | 502 | 2019 |
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study A He, B Merkel, JWL Brown, LZ Ryerson, I Kister, CB Malpas, S Sharmin, ... The Lancet Neurology 19 (4), 307-316, 2020 | 319 | 2020 |
DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France MP Sormani, M Salvetti, P Labauge, I Schiavetti, H Zephir, L Carmisciano, ... Annals of Clinical and Translational Neurology 8 (8), 1738-1744, 2021 | 115 | 2021 |
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome D Ferraro, AM Simone, R Bedin, V Galli, F Vitetta, L Federzoni, R D'Amico, ... Journal of neuroimmunology 257 (1-2), 76-81, 2013 | 95 | 2013 |
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis T Kalincik, EK Havrdova, D Horakova, G Izquierdo, A Prat, M Girard, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (4), 458-468, 2019 | 94 | 2019 |
Risk of secondary progressive multiple sclerosis: a longitudinal study A Fambiatos, V Jokubaitis, D Horakova, E Kubala Havrdova, M Trojano, ... Multiple Sclerosis Journal 26 (1), 79-90, 2020 | 89 | 2020 |
Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study D Mei, A Capuano, C Vollono, M Evangelista, D Ferraro, P Tonali, ... Neurological sciences 25, 245-250, 2004 | 88 | 2004 |
Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV M Nasi, M Pinti, S De Biasi, L Gibellini, D Ferraro, C Mussini, ... Immunology letters 162 (1), 329-333, 2014 | 82 | 2014 |
Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine D Mei, D Ferraro, G Zelano, A Capuano, C Vollono, C Gabriele, ... Clinical neuropharmacology 29 (5), 269-275, 2006 | 78 | 2006 |
Effect of disease-modifying therapy on disability in relapsing-remitting multiple sclerosis over 15 years T Kalincik, I Diouf, S Sharmin, C Malpas, T Spelman, D Horakova, ... Neurology 96 (5), e783-e797, 2021 | 75 | 2021 |
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis M Di Filippo, C Cordioli, S Malucchi, P Annovazzi, P Cavalla, VT Clerici, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (4), 448-450, 2022 | 71 | 2022 |
Systematic assessment and characterization of chronic pain in multiple sclerosis patients D Ferraro, D Plantone, F Morselli, G Dallari, AM Simone, F Vitetta, P Sola, ... Neurological Sciences 39, 445-453, 2018 | 67 | 2018 |
A quantitative comparison of BOLD fMRI responses to noxious and innocuous stimuli in the human spinal cord PE Summers, D Ferraro, D Duzzi, F Lui, GD Iannetti, CA Porro Neuroimage 50 (4), 1408-1415, 2010 | 67 | 2010 |
Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: a laser-evoked potential study C Pazzaglia, C Vollono, D Ferraro, D Virdis, V Lupi, D Le Pera, P Tonali, ... PAIN® 149 (2), 379-385, 2010 | 63 | 2010 |
Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study A Fasano, N Fini, D Ferraro, L Ferri, M Vinceti, Errals, J Mandrioli Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18 (3-4), 233-242, 2017 | 61 | 2017 |
Definitive childlessness in women with multiple sclerosis: a multicenter study D Ferraro, AM Simone, G Adani, F Vitetta, C Mauri, S Strumia, C Senesi, ... Neurological Sciences 38, 1453-1459, 2017 | 60 | 2017 |
Habituation to Pain in “Medication Overuse Headache”: A CO2 Laser‐Evoked Potential Study D Ferraro, C Vollono, R Miliucci, D Virdis, L De Armas, C Pazzaglia, ... Headache: The Journal of Head and Face Pain 52 (5), 792-807, 2012 | 57 | 2012 |
Cell-based assays for the detection of MOG antibodies: a comparative study M Gastaldi, S Scaranzin, S Jarius, B Wildeman, E Zardini, G Mallucci, ... Journal of Neurology 267, 3555-3564, 2020 | 55 | 2020 |
“Better explanations” in multiple sclerosis diagnostic workup: a 3-year longitudinal study M Calabrese, C Gasperini, C Tortorella, G Schiavi, G Frisullo, ... Neurology 92 (22), e2527-e2537, 2019 | 55 | 2019 |
Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: association with oligoclonal IgM bands and prediction of multiple sclerosis diagnosis D Ferraro, V Galli, F Vitetta, AM Simone, R Bedin, C Del Giovane, ... Journal of neuroimmunology 283, 64-69, 2015 | 54 | 2015 |